Hummingbird Bioscience, a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat diseases, today announced it has granted Immunome, Inc. (Nasdaq: IMNM) ...
Direct comparative efficacy studies are few, and also may have design issues, which make their interpretation difficult. The most serious safety issues for monoclonal antibodies include the risk ...
Monoclonal Antibody to Inhibit IL33 for Autoimmune Disorders is under clinical development by Eli Lilly and Co and currently in Phase I for Autoimmune Disorders.
Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company and HBM Holdings Limited ("Harbour BioMed") (together with the Company, the "Licensors"), have entered into an exclusive ...
Stämm unveiled breakthrough results of its continuous bioreactor for monoclonal antibody production with pilot studies in ...
CLYM116, an Fc-engineered anti-APRIL monoclonal antibody, has the potential to address limitations ... Transaction Details ...
GlobalData on MSN1d
KeyMed partners with US-based biotech Prolium in bispecific antibody dealInvestment company RTW Investments has launched a new biotech company called Prolium Bioscience, to advance the development ...
ThePrint on MSN1d
2nd ‘living drug’ against blood cancer gets regulatory nod. All about Qartemi, made in IndiaTherapy will cost Rs 35 to 50 lakh. India sees around 1.20 lakh new blood cancer cases and over 70,000 deaths annually from ...
This morning’s release made no mention of IK-595 or any other ... Meanwhile, Sanofi is working on amlitelimab, a monoclonal antibody [mAb] that targets OX40-ligand In this morning’s release ...
Funding will propel Leyden Labs’ non-vaccine intranasal antibody programs to safeguard people from respiratory viruses. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback